Naklofen 20 tablets 50mg DICLOFENACUM Наклофен

Naklofen Indications

Oral administration:

- inflammatory rheumatic diseases: rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, spondylitis, pain of various localization, extra-articular rheumatism;
- post-traumatic and post-operative pain, inflammation and swelling;
- pain and / or inflammatory conditions in gynecology (for example, primary dysmenorrhea, adnexitis).
- migraine 

- injuries of tendons, ligaments, muscles and joints (due to sprains, strains, bruises, sports injuries);
- localized forms of soft tissue rheumatism: tendonitis (including "tennis elbow"), bursitis, and shoulder syndrome periartropatiya localized degenerative forms of rheumatism (osteoarthritis peripheral joints and spine).

- inflammatory and degenerative forms of rheumatism, rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, spondylitis, vertebral pain, extra-articular rheumatism;

- acute attacks of gout;
- renal and hepatic colic;
- pain and swelling after injuries and operations;
- severe migraine attacks.

Application

Tablet taken orally during or after a meal, not liquid, squeezed small amounts of water. Adults are administered in an initial dose of 100-150 mg / day depending on the severity of the disease; usual maintenance dose - 100 mg / day.

Children under the age of 14 years with juvenile arthritis, the daily dose is 1-3 mg of diclofenac per 1 kg of body weight, which should be divided into 2-3 doses. If reception Naklofena tablets combined with other dosage forms it should take into account the total daily dose of the drug.

The daily dose is 150 mg of diclofenac and depends on the severity of the disease.

Contradictions

Hypersensitivity to diclofenac or other ingredients;
gastric ulcer and duodenal ulcer in the active form, gastrointestinal bleeding or perforation;
severe heart failure (CH III-IV);
severe renal (creatinine clearance <30 mL / min) or hepatic insufficiency (class C Child-Pugh cirrhosis and ascites);
Diclofenac, like other NSAIDs, is contraindicated in patients who have asthma attacks, urticaria, or acute rhinitis, nasal polyps, and other allergic symptoms provoked by taking acetylsalicylic acid or other drugs with the ability to inhibit prostaglandin synthetase;
inflammatory bowel disease (Crohn's disease or ulcerative colitis);
treatment of post-operative pain following coronary artery bypass surgery (or the use of heart-lung machine).